
1001 - 5000 employees
Founded 2014
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M POST IPO EQUITY on 2026-04
Biotechnology • Pharmaceuticals
Revolution Medicines is an oncology company that discovers and develops targeted medicines for patients with RAS-addicted cancers. Its RAS(ON) tri-complex inhibitor platform supports a portfolio of investigational oral therapies designed to target the active, cancer-driving state of RAS.
🔥 47 minutes ago
Where this job comes from
Posted on Revolution Medicines's careers page ↗, not through a job board
First seen by Remote Rocketship 47 minutes ago
Still open on Revolution Medicines's site. Checked 34 minutes ago.

1001 - 5000 employees
Founded 2014
🧬 Biotechnology
💊 Pharmaceuticals
🔥 Funding within the last year
💰 $500M POST IPO EQUITY on 2026-04
Biotechnology • Pharmaceuticals
Revolution Medicines is an oncology company that discovers and develops targeted medicines for patients with RAS-addicted cancers. Its RAS(ON) tri-complex inhibitor platform supports a portfolio of investigational oral therapies designed to target the active, cancer-driving state of RAS.
• Establish and lead Revolution Medicines’ Corporate Affairs capability across Japan, Canada, Australia, Brazil and the broader ICON region • Develop and execute an integrated regional Corporate Affairs strategy across external and internal communications and corporate reputation • Shape healthcare environments that improve cancer outcomes, strengthen healthcare systems and enable timely access to innovation • Translate global priorities into locally relevant strategies and ensure country perspectives inform enterprise decisions • Establish an integrated ICON strategy and scalable Corporate Affairs network with country priorities, accountabilities and impact measures • Deliver coordinated corporate and launch communications, stakeholder governance, issues management and crisis preparedness • Build relationships with industry associations and strengthen the company’s reputation and understanding of patient needs • Advise regional leaders and country General Managers on reputational developments • Set annual priorities, budgets and performance measures; build a lean operating model • Recruit and develop talent and manage specialist partners • Develop regional narratives, adapt global messaging and build media relationships • Coordinate communications for affiliate establishment, clinical milestones and launches • Plan launch communications and integrated campaigns with Medical Affairs, Market Access and Commercial teams • Develop regional and country internal communications and employee engagement plans • Establish regional issues management and crisis communications preparedness • Collaborate with Medical Affairs and Government Affairs on engagement with professional societies, research institutions and policymakers • Report to the Senior Vice President, Corporate Affairs, with a dotted line to the Senior Vice President, Intercontinental (ICON)
• Degree in Communications, Life Sciences, Business or a related discipline • At least 15 years of relevant Corporate Affairs, Communications, or Public Affairs experience, including senior leadership responsibility in biopharmaceuticals • Demonstrated success developing and executing integrated Corporate Affairs strategies across multiple countries • Experience building corporate reputation, leading executive communications and managing sensitive issues or crises • Ability to build capabilities and deliver through lean teams, agencies and global matrix organizations • Sound strategic judgment, prioritization and budget management • Exceptional communication, storytelling and executive influencing skills • Ability to translate complex science and policy for non-specialists • Fluency in English • Oncology, precision medicine, biomarker-driven healthcare or rare diseases preferred • Affiliate establishment and international launch readiness in a high-growth or early commercial-stage biotechnology company preferred • Regional leadership across Asia-Pacific and Latin America, including direct experience in Japan, Canada, Australia or Brazil preferred • Distributor or partner-led markets, complex stakeholder partnerships and additional languages relevant to ICON preferred
• Opportunity to build Revolution Medicines’ Corporate Affairs capability from the ground up across a strategically important region • Opportunity to strengthen trusted partnerships, influence healthcare policy and help innovative precision medicines reach patients • Inclusive workplace where diverse perspectives drive innovation and improve outcomes for patients worldwide • Regular international travel across ICON markets and to Revolution Medicines’ global offices
Apply NowImprove your chances of getting an interview by checking your resume score before you apply.
🕒 5 days ago
Director leading global investigator site budgeting, forecasting, and cost analysis for BeOne’s oncology clinical operations. Managing governance, compliance, process optimization, and a worldwide budgeting team.
🕒 6 days ago
Associate Director leading BioMarin’s rare-disease commercial strategy across Australia and New Zealand. Driving sales, market access, brand execution, stakeholder engagement, and distributor performance.
🕒 November 10
Director of Alliances expanding Guidewire’s cloud insurance platform partnerships across APAC. Driving SI relationships, co-selling, partner strategy, and alliance revenue growth.
🕒 November 5
Data and Science Director leading conservation science, data, and MEL programs for The Nature Conservancy Australia. Guiding evidence-based initiatives, teams, funding, and organisational decision-making.
🕒 October 26
Director leading APAC EV Managed Services delivery for a global fleet-management technology company. Driving fleet electrification solutions, customer outcomes, regional growth, and team performance.